» Articles » PMID: 35056817

Melatonin Attenuates RANKL-Induced Osteoclastogenesis Via Inhibition of Atp6v0d2 and DC-STAMP Through MAPK and NFATc1 Signaling Pathways

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Jan 21
PMID 35056817
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: the cytotoxic effect of melatonin was investigated by MTT assay. Osteoclast differentiation and gene expression of osteoclast-related factors were confirmed via TRAP staining, pit formation assay, immunofluorescence imaging, western blot, and real-time PCR.

Results: melatonin was found to inactivate the p38 and JNK of MAP kinase in RAW264.7 cells treated with RANKL and treated with a combination RANKL and melatonin for 1, 3, and 5 days. The melatonin treatment group showed a reduction in osteoclastogenesis transcription factors and ATP6v0d2 gene expression.

Conclusions: melatonin inhibits osteoclast differentiation and cell fusion by inhibiting the expression of Atp6v0d2 through the inactivation of MAPK and NFATc1 signaling in RANKL-stimulated RAW264.7 macrophages. The findings of the present study suggest that melatonin could be a suitable therapy for bone loss and imply a potential role of melatonin in bone health.

Citing Articles

Melatonin Regulates Osteoblast Differentiation through the m6A Reader hnRNPA2B1 under Simulated Microgravity.

Sun Q, Xu L, Hu Z, Liu J, Yu T, Li M Curr Issues Mol Biol. 2024; 46(9):9624-9638.

PMID: 39329924 PMC: 11430354. DOI: 10.3390/cimb46090572.


Comparison of three different lactic acid bacteria-fermented proteins on RAW 264.7 osteoclast and MC3T3-E1 osteoblast differentiation.

Kim J, Song H, Cheon S, An S, Lee C, Kim S Sci Rep. 2023; 13(1):21575.

PMID: 38062113 PMC: 10703878. DOI: 10.1038/s41598-023-49024-1.


Small-molecule amines: a big role in the regulation of bone homeostasis.

Zhang Q, Yang J, Hu N, Liu J, Yu H, Pan H Bone Res. 2023; 11(1):40.

PMID: 37482549 PMC: 10363555. DOI: 10.1038/s41413-023-00262-z.


Beneficial Effects of Melatonin on Periodontitis Management: Far More Than Oral Cavity.

Wang C, Wang L, Wang X, Cao Z Int J Mol Sci. 2022; 23(23).

PMID: 36498871 PMC: 9739298. DOI: 10.3390/ijms232314541.


The role of melatonin in the development of postmenopausal osteoporosis.

Yang K, Qiu X, Cao L, Qiu S Front Pharmacol. 2022; 13:975181.

PMID: 36278157 PMC: 9585202. DOI: 10.3389/fphar.2022.975181.


References
1.
Ping Z, Hu X, Wang L, Shi J, Tao Y, Wu X . Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway. Acta Biomater. 2017; 51:513-525. DOI: 10.1016/j.actbio.2017.01.034. View

2.
Kotlarczyk M, Lassila H, ONeil C, DAmico F, Enderby L, Witt-Enderby P . Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res. 2012; 52(4):414-26. DOI: 10.1111/j.1600-079X.2011.00956.x. View

3.
Rody Jr W, King G, Gu G . Osteoclast recruitment to sites of compression in orthodontic tooth movement. Am J Orthod Dentofacial Orthop. 2001; 120(5):477-89. DOI: 10.1067/mod.2001.118623. View

4.
Satue M, Ramis J, Arriero M, Monjo M . A new role for 5-methoxytryptophol on bone cells function in vitro. J Cell Biochem. 2014; 116(4):551-8. DOI: 10.1002/jcb.25005. View

5.
Lee K, Seo I, Choi M, Jeong D . Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology. Int J Mol Sci. 2018; 19(10). PMC: 6213329. DOI: 10.3390/ijms19103004. View